Remove topic patient-engagement
article thumbnail

Post-event glimpse into the Pharma Industry Townhall

Express Pharma

The event garnered widespread acclaim for its focus on updating professionals on new-age skill sets and gaining in-depth knowledge of trending topics to address today’s day and age challenges in the sales and marketing realm of the Pharma Industry. The trending topics were discussed in four talks & presentation formats.

article thumbnail

PHARMAP 2024 held in Amsterdam, marks its fourth edition

Express Pharma

Topics of sessions delved into the future of pharmaceutical manufacturing, focusing on Industry 4.0 Presentations covered diverse topics: Erika Diago Rufino, Director Regulatory Affairs of Johnson and Johnson Innovative Medicine, talked about e-labeling in Brazil. and Produlab Pharma. advancements like MES and robotics.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

5 best practices for improving patient engagement

pharmaphorum

Life science companies invest a significant number of resources to engage physicians and patient advocates. However, companies often fall short when it comes to engaging patients in a meaningful way during the product development process. Real-world examples of patient engagement success. indicates required.

98
article thumbnail

Breaking Down the 2024 PRITE Blueprint

Board Vitals - Pharmacist

The PRITE covers a broad range of topics within the field of psychiatry. Administered annually, it covers a wide array of topics to ensure a well-rounded evaluation of a resident’s understanding of psychiatry. What is the PRITE ? What is the PRITE ? Let’s break down the latest PRITE blueprint : A.

98
article thumbnail

How Generative Artificial Intelligence is Changing Patient Advocacy

Putting Patients First Blog

My previous experience with this topic includes authoring a research paper on the ethical use of this type of technology and attending seminars on this topic. Generative AI Adoption by Patient Groups My primary finding was that the adoption of GenAI within the patient community is still in its infancy.

article thumbnail

Engaging change: Connecting patients and regulators can move the dial on drug development

pharmaphorum

Face-to-face discussion educates regulators on what matters most to patients, and guides future decision-making. Regulators are increasingly asking drug developers to include the patient voice in submissions, but the best way to go about this is less clear-cut. The rise of patient centricity. “We

article thumbnail

2nd Annual Gene Therapy Patient Engagement Summit

pharmaphorum

As investment in gene therapies continues to grow rapidly, more effectively engaging patients throughout development has become a priority for any company serious about building safer and more meaningful gene therapy programs. The post 2nd Annual Gene Therapy Patient Engagement Summit appeared first on.